Literature DB >> 27824743

Managing Recurring Obstetric Cholestasis With Metformin.

Abdullatif Elfituri1, Amanda Ali, Hassan Shehata.   

Abstract

BACKGROUND: Obstetric cholestasis is a pregnancy-related disorder associated with an adverse pregnancy outcome. It is characterized by generalized pruritus, elevated bile acids, and abnormal liver enzymes. Recent publications show that obstetric cholestasis is associated with, and likely to potentiate, the risk of developing gestational diabetes mellitus. CASE: This case describes an unusual pattern of the disease, in which obstetric cholestasis occurred in five consecutive pregnancies with a different course of the disease in the fifth pregnancy.
CONCLUSION: A patient with recurrent cholestasis of pregnancy had worsening disease in her first four pregnancies. In her fifth pregnancy, treatment for gestational diabetes mellitus with metformin was associated with a lowering effect on bile acids and liver enzymes, indicating a possible role for metformin in the management of obstetric cholestasis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27824743     DOI: 10.1097/AOG.0000000000001748

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

1.  Metformin in gestational diabetes mellitus.

Authors:  Reva Tripathi; Shakun Tyagi; Vandana Goel
Journal:  Indian J Med Res       Date:  2017-05       Impact factor: 2.375

2.  The prevalence and pregnancy outcomes of intrahepatic cholestasis of pregnancy: A retrospective clinical audit review.

Authors:  Fergus W Gardiner; Ruth McCuaig; Chris Arthur; Thomas Carins; Adam Morton; Josephine Laurie; Teresa Neeman; Boon Lim; Michael J Peek
Journal:  Obstet Med       Date:  2018-10-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.